Define and describe schizophrenia
Positive symptoms- Delusions, hallucinations, thought disorder
Which neurones and receptors are affected in schizophrenia?
Is it developmental or degenerative?
Developmental-
brain structure abnormalities present at onset of psychosis and not progressive
- Enlarged ventricles and reduced temporal lobe vol (6-10%)- hippocampus
Describe:
Early lesion hypothesis
Late lesion hypothesis
Early lesion- Foetal or perinatal event- virus, hypoxia, premature, low birth weight birth interacting with normal development
- Late lesion- deviation in maturation during adolescence- cannabis?
How are dopamine pathways affected?
Mesocortical - reduced
Mesolimbic- ventral tegmental area enhanced
Describe amphetamine psychosis
Release of DA in brain
Amphetamine effects antagonised by antipsychotics/neuroleptic drugs
Anti psychotics are D2 receptor antagonists
Which is more effective- alpha or beta flupenthixol
a isomer
List the extra pyramidal side effects of Chlorpromazine
H1 antagonist- sedation
D2 antagonism in chemoreceptor zone- antiemesis
Tuberoinfundibular pathway- hyperprolactinaemia
Nigrostriatal pathway- extra pyramidal effects
Acute dystonia
Parkinsonism- lack of dopamine in striatum
Akathisia
Tardive dyskinesia- dopamine excess in striatum
How do dopamine antagonists affect prolactin?
increase prolactin release
Describe 4 types of dopamine receptors
D1- post synaptic (&D5 excitatory, increase cAMP)
D2- pre and post
D3- post synaptic, in nucleus accumbens (decrease cAMP) not in striatum
D4- low expression cortex and limbic system
When is Clozapine used?
Pt resistant to benefit from 2 other antipsychotics
5HT serotonin receptor antagonism in frontal cortex
D2 antagonism in mesolimbic pathway
Works for +ve symptoms, less for -ve
combined with CBT
Side effects: lower affinity for D2 receptors- less EP side effects
No hyperprolactinaemia
Muscarinic receptor antagonism
Alpha1 antagonism- miosis, cutaneous flushes, postural hypotension
5HT2 antagonism- increased appetite, weight gain
Describe attention deficit hyperactivity disorder (ADHD)
Inattentive, impulsive and hyperactive behaviour- early onset
Describe how ADHD is treated
Non pharmological behavioural therapy - Stimulant drugs- release DA and NA - Methylphenidate- DA reuptake blocker - Dexamphetamine- reuptake blocker and causes release - New drugs non stimulants Reuptake inhibitor- atomexetine a2 agonist- guanfacine - Increase cortical function- improve attention